" /> Brivanib Alaninate - CISMeF





Preferred Label : Brivanib Alaninate;

NCIt definition : The alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression.;

Alternative definition : NCI-GLOSS: A substance being studied in the treatment of cancer. Brivanib alaninate may prevent the growth of new blood vessels that tumors need to grow and may kill cancer cells. It is a type of vascular endothelial growth factor receptor 2 inhibitor and a type of antiangiogenesis agent.;

UNII : U2Y5OFN795;

InChIKey : LTEJRLHKIYCEOX-OCCSQVGLSA-N;

CAS number : 649735-63-7; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 649735-63-7 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : BMS 582664; BMS-582664;

Chemical formula : C22H24FN5O4;

Codes from synonyms : CDR0000600439;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
16/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.